secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensus Healthcare, Inc. (SRTS)
CIK:        0001494891
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0001213900-24-041314
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensus Healthcare Q1 revenue $10.7M (up 214% YoY); net income $2.3M vs loss of $1.9M
--------------------------------------------------------------------------------

- Revenue $10.7M, up 214% from $3.4M; shipped 26 systems vs 10 YoY.
- Net income $2.3M ($0.14 diluted EPS) vs net loss $1.9M ($0.12 loss) YoY.
- Adjusted EBITDA $3.0M vs negative $2.7M YoY.
- Launched 'Fair Deal Agreement' recurring revenue program; cash $14.7M, no debt.
- Sold first SRT-100 Vision in Asia (Taiwan) and first veterinary unit outside U.S. (Israel).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1494891/000121390024041314/0001213900-24-041314-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1494891/000121390024041314/ea0205344-8k_sensus.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-041314

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer